4//SEC Filing
NOVELION THERAPEUTICS INC. 4
Accession 0001104659-16-163871
CIK 0000827809operating
Filed
Dec 26, 7:00 PM ET
Accepted
Dec 27, 4:05 PM ET
Size
6.1 KB
Accession
0001104659-16-163871
Insider Transaction Report
Form 4
Louis Roger
See Remarks
Transactions
- Award
Stock Option (right to buy)
2016-12-22+41,740→ 41,740 totalExercise: $8.65Exp: 2026-12-22→ Common Shares (41,740 underlying)
Footnotes (2)
- [F1]Each option has an exercise price equal to the closing price of a common share of the Issuer on the Nasdaq Global Select Market on the grant date.
- [F2]Subject, with limited exceptions, to the Reporting Person's continued employment with the Issuer or one of its affiliates, 13,913 common shares underlying this stock option award will vest on December 22, 2017, 13,913 common shares underlying this stock option award will vest on December 22, 2018 and 13,914 common shares underlying this stock option award will vest on December 22, 2019.
Documents
Issuer
NOVELION THERAPEUTICS INC.
CIK 0000827809
Entity typeoperating
IncorporatedBritish Columbia, Canada
Related Parties
1- filerCIK 0000827809
Filing Metadata
- Form type
- 4
- Filed
- Dec 26, 7:00 PM ET
- Accepted
- Dec 27, 4:05 PM ET
- Size
- 6.1 KB